企业人事变动
Search documents
湾财周报 人物 方洪波谈“董小姐”背后;“顶流”张坤卸任
Nan Fang Du Shi Bao· 2025-05-18 11:38
Group 1: Corporate Developments - Midea Group's chairman Fang Hongbo commented on succession issues, referencing the ongoing rivalry with Gree Electric's chairwoman Dong Mingzhu, highlighting the competitive dynamics between the two companies over the past 13 years [4] - Red Star Macalline's founder Che Jianxing is under investigation by the Yunnan Provincial Supervisory Committee, following previous debt crises and strategic adjustments, while the company's board operations remain normal [6] - China Telecom appointed Liu Guiqing as president and Huang Zhiyong as executive vice president, indicating a shift in leadership [8] Group 2: Personnel Changes - Wang Yuwen has taken over as chairman of Shenye Group, succeeding Lu Hua, who retired after 12 years, marking a significant leadership transition [9] - Xu Minfeng, a veteran of Midea, has left his position as president of the home appliance division, with reports indicating he had already departed in September of the previous year [10] - Zhang Kun has resigned as vice president of E Fund to focus on investment management, reflecting a trend in the industry towards prioritizing investment research [11] - Wu Chaoze has been appointed as a committee member of CITIC Securities, continuing her role in research and international business [12] Group 3: Legal and Regulatory Issues - A retail investor was fined nearly 300 million yuan for manipulating the securities market, highlighting regulatory scrutiny in the financial sector [7] - Former vice president of China Merchants Bank, Ding Wei, has been prosecuted for accepting bribes, indicating ongoing anti-corruption efforts within the banking industry [13]
泰山酒业高层人事调整:新增王波、张小峰两位董事
Sou Hu Cai Jing· 2025-04-27 22:33
Core Viewpoint - The recent management changes at Taishan Liquor Group highlight a transition in leadership while the company continues to achieve record financial performance and maintain its position as a leading player in the Shandong liquor industry [1][3]. Management Changes - On April 23, 2023, Taishan Liquor Group experienced a change in its board of directors, with Liu Hanping and Ma Xiyuan stepping down and Wang Bo and Zhang Xiaofeng taking over [1]. - Wang Bo holds a 6% stake in the company and previously served as a supervisor [1]. - Ma Xiyuan, the former chairman who passed away on January 27, 2023, held a 6% stake, while Liu Hanping held 5% through Dongguan Huasheng Industrial [3]. Company Performance - Taishan Liquor Group has been recognized as the 17th largest liquor company in China in 2024, maintaining its status as the top liquor producer in Shandong for several consecutive years [3]. - The company reported record highs in revenue, taxes, and profits, with total profits and taxes reaching 470 million yuan, leading the Shandong liquor industry for four consecutive years [3]. - The success is attributed to three main factors: quality, brand, and service [3]. Investment Activities - In addition to its core liquor business, Taishan Liquor Group has significant investments in the financial sector, holding 3.03% of Tai'an Bank and stakes in several local financial companies [4]. - The company owns 49% of Tai'an High-tech Zone Qianbang Microfinance, 5.25% of Tai'an District Taitong Microfinance, 40% of Tai'an Zhengda Pawn, 80% of Shandong Jinze SME Emergency Loan Fund, and 30% of Tai'an Purun Investment [4]. - Taishan Liquor Group also holds a 16.78% stake in Shandong Taishan Shengliyuan Group, which reported revenues of 1.075 billion yuan in 2023 [4].
21健讯Daily|全国药监系统启动药品经营环节“清源”行动;住友制药35亿元出售亚洲业务
2 1 Shi Ji Jing Ji Bao Dao· 2025-04-07 02:54
4月3日,国家药监局发布公告,根据《处方药与非处方药分类管理办法(试行)》(原国家药品监督管 理局令第10号)规定,经国家药监局组织论证和审核,经前舒颗粒和复方太子参口服液由处方药转换为 非处方药。公告称,相关药品上市许可持有人于2025年12月27日前,就修订说明书事项向省级药品监督 管理部门备案,并将说明书修订的内容及时通知相关医疗机构、药品经营企业等单位。 全国药监系统启动药品经营环节"清源"行动 4月3日,国家药监局召开药品经营环节"清源"行动部署会。会议强调,开展"清源"行动是贯彻落实中央 纪委国家监委关于集中整治群众身边不正之风和腐败问题工作的重要举措。各级药监部门要压实责任, 紧盯群众反映强烈的突出问题,切实排查化解风险隐患,打击药品经营违法行为,规范网售业态,严防 假劣药流入。要突出重点,加大案件查办力度,强化上下协同联动和跨部门查办协作,用好信息化手 段,规范涉企检查,确保"清源"行动取得实效。 政策动向 经前舒颗粒和复方太子参口服液转换为非处方药 21点评:国家药监局启动药品经营环节"清源"行动,彰显了监管部门整治药品市场乱象的决心。此举不 仅是回应群众关切、保障用药安全的关键举措,更是推 ...